Niyazi M - Search Results

1

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.

Weller J, Katzendobler S, Blobner J, Thiele F, Becker H, Quach S, Egensperger R, Niyazi M, Suchorska B, Thon N, Weller M, Tonn JC. Weller J, et al. Among authors: niyazi m. J Neurooncol. 2022 Oct;160(1):149-158. doi: 10.1007/s11060-022-04128-y. Epub 2022 Sep 16. J Neurooncol. 2022. PMID: 36112301 Free PMC article.

2

FET-PET for malignant glioma treatment planning.

Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093

3

Radiotherapy with and without temozolomide in elderly patients with glioblastoma.

Niyazi M, Schwarz SB, Suchorska B, Belka C. Niyazi M, et al. Strahlenther Onkol. 2012 Feb;188(2):154-9. doi: 10.1007/s00066-011-0026-7. Epub 2012 Jan 11. Strahlenther Onkol. 2012. PMID: 22231634

4

Iodine-125 brachytherapy for brain tumours--a review.

Schwarz SB, Thon N, Nikolajek K, Niyazi M, Tonn JC, Belka C, Kreth FW. Schwarz SB, et al. Among authors: niyazi m. Radiat Oncol. 2012 Mar 6;7:30. doi: 10.1186/1748-717X-7-30. Radiat Oncol. 2012. PMID: 22394548 Free PMC article. Review.

5

Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival.

Manapov F, Klöcking S, Niyazi M, Levitskiy V, Belka C, Hildebrandt G, Fietkau R, Klautke G. Manapov F, et al. Among authors: niyazi m. J Neurooncol. 2012 Sep;109(2):309-14. doi: 10.1007/s11060-012-0894-4. Epub 2012 May 20. J Neurooncol. 2012. PMID: 22610939

6

FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.

Niyazi M, Schnell O, Suchorska B, Schwarz SB, Ganswindt U, Geisler J, Bartenstein P, Kreth FW, Tonn JC, Eigenbrod S, Belka C, la Fougère C. Niyazi M, et al. Radiother Oncol. 2012 Jul;104(1):78-82. doi: 10.1016/j.radonc.2012.04.022. Epub 2012 Jun 5. Radiother Oncol. 2012. PMID: 22673727

7

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

Niyazi M, Jansen N, Ganswindt U, Schwarz SB, Geisler J, Schnell O, Büsing K, Eigenbrod S, la Fougère C, Belka C. Niyazi M, et al. J Neurooncol. 2012 Dec;110(3):389-95. doi: 10.1007/s11060-012-0980-7. Epub 2012 Oct 4. J Neurooncol. 2012. PMID: 23054562

8

Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.

Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougère C. Jansen NL, et al. Among authors: niyazi m. J Nucl Med. 2014 Feb;55(2):198-203. doi: 10.2967/jnumed.113.122333. Epub 2013 Dec 30. J Nucl Med. 2014. PMID: 24379223 Free article.

9

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option.

Flieger M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, la Fougère C, Ertl L, Linn J, Herrlinger U, Belka C, Niyazi M. Flieger M, et al. Among authors: niyazi m. J Neurooncol. 2014 Apr;117(2):337-45. doi: 10.1007/s11060-014-1394-5. Epub 2014 Feb 7. J Neurooncol. 2014. PMID: 24504501

10

Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma.

Jansen NL, Suchorska B, Wenter V, Schmid-Tannwald C, Todica A, Eigenbrod S, Niyazi M, Tonn JC, Bartenstein P, Kreth FW, la Fougère C. Jansen NL, et al. Among authors: niyazi m. J Nucl Med. 2015 Jan;56(1):9-15. doi: 10.2967/jnumed.114.144675. J Nucl Med. 2015. PMID: 25537990 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page